Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Adjuvant treatment duration for high-risk stage II colon cancer

Panel discussion

Date

30 Sep 2019

Session

Adjuvant treatment duration for high-risk stage II colon cancer

Topics

Tumour Site

Gastrointestinal Cancers

Presenters

Claus-Henning Koehne

Authors

A. Sobrero1, C. Koehne2

Author affiliations

  • 1 Department Of Medical Oncology, IRCCS AOU San Martino - IST-Istituto Nazionale per la Ricerca sul Cancro, 16132 - Genova/IT
  • 2 Universitätsklinik Onkologie / Hämatologie, Klinikum Oldenburg, 26133 - Oldenburg/DE

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.